153 related articles for article (PubMed ID: 31080993)
41. The effects of GLUT1 on the survival of head and neck squamous cell carcinoma.
Li S; Yang X; Wang P; Ran X
Cell Physiol Biochem; 2013; 32(3):624-34. PubMed ID: 24022001
[TBL] [Abstract][Full Text] [Related]
42. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
43. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
[TBL] [Abstract][Full Text] [Related]
44. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
[TBL] [Abstract][Full Text] [Related]
46. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
Dai J; Wei W
Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
[TBL] [Abstract][Full Text] [Related]
47. LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer).
Simonik EA; Cai Y; Kimmelshue KN; Brantley-Sieders DM; Loomans HA; Andl CD; Westlake GM; Youngblood VM; Chen J; Yarbrough WG; Brown BT; Nagarajan L; Brandt SJ
PLoS One; 2016; 11(10):e0164804. PubMed ID: 27780223
[TBL] [Abstract][Full Text] [Related]
48. Effects of PTEN gene silencing on invasion and EMT in oral squamous carcinoma Tca8113 cells.
Lu Z; Guo H; Lin Y; Shen L; Yin C; Xie S
J Oral Pathol Med; 2017 Jan; 46(1):31-38. PubMed ID: 27591748
[TBL] [Abstract][Full Text] [Related]
49. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
50. CDH3 is associated with poor prognosis by promoting the malignancy and chemoresistance in oral squamous cell carcinoma.
Wu T; Xiao Z; Li Y; Jiao Z; Liang X; Zhang Y; Liu H; Yang A
Asian J Surg; 2022 Dec; 45(12):2651-2658. PubMed ID: 35305877
[TBL] [Abstract][Full Text] [Related]
51. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
[TBL] [Abstract][Full Text] [Related]
52. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
[TBL] [Abstract][Full Text] [Related]
53. ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy.
Fu G; Somasundaram RT; Jessa F; Srivastava G; MacMillan C; Witterick I; Walfish PG; Ralhan R
Oncotarget; 2016 Mar; 7(13):17162-81. PubMed ID: 26934445
[TBL] [Abstract][Full Text] [Related]
54. Bone invasion-targeted chemotherapy with a novel anionic platinum complex (3Pt) for oral squamous cell carcinoma.
Kasahara Y; Endo K; Ueno T; Ueno H; Moriyama-Kita M; Odani A; Yoshizaki T
Cancer Sci; 2019 Oct; 110(10):3288-3295. PubMed ID: 31348586
[TBL] [Abstract][Full Text] [Related]
55. miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma.
Feng J; Qi B; Guo L; Chen LY; Wei XF; Liu YZ; Zhao BS
World J Gastroenterol; 2017 Jun; 23(23):4243-4251. PubMed ID: 28694664
[TBL] [Abstract][Full Text] [Related]
56. FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma.
Zheng X; Jia B; Lin X; Han J; Qiu X; Chu H; Sun X; Hu W; Pan J; Chen J; Zhao J
Int J Mol Med; 2016 Nov; 38(5):1443-1449. PubMed ID: 27666346
[TBL] [Abstract][Full Text] [Related]
57. LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
Wang B; Feng P; Xiao Z; Ren EC
J Hepatol; 2009 Mar; 50(3):528-37. PubMed ID: 19155088
[TBL] [Abstract][Full Text] [Related]
58. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines.
Weng J; Wang C; Wang Y; Tang H; Liang J; Liu X; Huang H; Hou J
Oral Oncol; 2014 Oct; 50(10):983-90. PubMed ID: 25096824
[TBL] [Abstract][Full Text] [Related]
59. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
60. Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma.
Goto RN; Sobral LM; Sousa LO; Garcia CB; Lopes NP; Marín-Prida J; Ochoa-Rodríguez E; Verdecia-Reyes Y; Pardo-Andreu GL; Curti C; Leopoldino AM
Eur J Pharmacol; 2018 Jan; 819():198-206. PubMed ID: 29221949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
